Review article
Antiplatelet Therapy in Cerebrovascular Diseases
Frederic-Ivan Silconi
Full text: croatian pdf 97 Kb
page 77-84
downloads: 1.049
cite
APA 6th Edition
Silconi, F. (2022). Antiplatelet Therapy in Cerebrovascular Diseases. Medicus, 31 (1 Moždani udar), 77-77. Retrieved from https://hrcak.srce.hr/275919
MLA 8th Edition
Silconi, Frederic-Ivan. "Antiplatelet Therapy in Cerebrovascular Diseases." Medicus, vol. 31, no. 1 Moždani udar, 2022, pp. 77-77. https://hrcak.srce.hr/275919. Accessed 22 Nov. 2024.
Chicago 17th Edition
Silconi, Frederic-Ivan. "Antiplatelet Therapy in Cerebrovascular Diseases." Medicus 31, no. 1 Moždani udar (2022): 77-77. https://hrcak.srce.hr/275919
Harvard
Silconi, F. (2022). 'Antiplatelet Therapy in Cerebrovascular Diseases', Medicus, 31(1 Moždani udar), pp. 77-77. Available at: https://hrcak.srce.hr/275919 (Accessed 22 November 2024)
Vancouver
Silconi F. Antiplatelet Therapy in Cerebrovascular Diseases. Medicus [Internet]. 2022 [cited 2024 November 22];31(1 Moždani udar):77-77. Available from: https://hrcak.srce.hr/275919
IEEE
F. Silconi, "Antiplatelet Therapy in Cerebrovascular Diseases", Medicus, vol.31, no. 1 Moždani udar, pp. 77-77, 2022. [Online]. Available: https://hrcak.srce.hr/275919. [Accessed: 22 November 2024]
Full text: english pdf 97 Kb
page 77-77
downloads: 281
cite
APA 6th Edition
Silconi, F. (2022). Antiplatelet Therapy in Cerebrovascular Diseases. Medicus, 31 (1 Moždani udar), 77-77. Retrieved from https://hrcak.srce.hr/275919
MLA 8th Edition
Silconi, Frederic-Ivan. "Antiplatelet Therapy in Cerebrovascular Diseases." Medicus, vol. 31, no. 1 Moždani udar, 2022, pp. 77-77. https://hrcak.srce.hr/275919. Accessed 22 Nov. 2024.
Chicago 17th Edition
Silconi, Frederic-Ivan. "Antiplatelet Therapy in Cerebrovascular Diseases." Medicus 31, no. 1 Moždani udar (2022): 77-77. https://hrcak.srce.hr/275919
Harvard
Silconi, F. (2022). 'Antiplatelet Therapy in Cerebrovascular Diseases', Medicus, 31(1 Moždani udar), pp. 77-77. Available at: https://hrcak.srce.hr/275919 (Accessed 22 November 2024)
Vancouver
Silconi F. Antiplatelet Therapy in Cerebrovascular Diseases. Medicus [Internet]. 2022 [cited 2024 November 22];31(1 Moždani udar):77-77. Available from: https://hrcak.srce.hr/275919
IEEE
F. Silconi, "Antiplatelet Therapy in Cerebrovascular Diseases", Medicus, vol.31, no. 1 Moždani udar, pp. 77-77, 2022. [Online]. Available: https://hrcak.srce.hr/275919. [Accessed: 22 November 2024]
Abstract
Antiplatelet therapy has been used in clinical practice for many years in patients with acute coronary syndrome, stroke or other cerebrovascular diseases. Taking in consideration the benefits of these drugs, on rare occasions they may cause life threatening complications. The use of different antithrombotic drugs has been quite confusing so there is a need to create guidelines in order to facilitate the decision-making process. Of course, in addition to the existing guidelines, it is necessary to consider the benefits and possible risk for each patient individually. Such an approach may lead to dilemmas related to each individual drug based on recommendations. This review tries to give a cross-section of the current situation in antiplatelet therapy.
Keywords
stroke; antiplatelet therapy; monotherapy; dual therapy; acetylsalicylic acid; clopidogrel; ticagrelor
Hrčak ID:
275919
URI
https://hrcak.srce.hr/275919
Publication date:
2.5.2022.
Article data in other languages:
croatian
Visits: 2.060
*
